Searched for: subject%3A%22Cholesterol%255C%2Bblood%255C%2Blevel%22
(1 - 20 of 106)

Pages

A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In Vivo
A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In Vivo
Effectiveness of a Worksite Intervention for Male Construction Workers on Dietary and Physical Activity Behaviors, Body Mass Index, and Health Outcomes
Effectiveness of a Worksite Intervention for Male Construction Workers on Dietary and Physical Activity Behaviors, Body Mass Index, and Health Outcomes: Results of a Randomized Controlled Trial
Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis
Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis
Ranges of phenotypic flexibility in healthy subjects
Ranges of phenotypic flexibility in healthy subjects
A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice
A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice
Effects of anthocyanin and flavanol compunds on lipid metabolism and adipose tissue associated systemic inflammation in diet-induced obesity
Effects of anthocyanin and flavanol compunds on lipid metabolism and adipose tissue associated systemic inflammation in diet-induced obesity
Weight loss predictability by plasma metabolic signatures in adults with obesity and morbid obesity of the DiOGenes study
Weight loss predictability by plasma metabolic signatures in adults with obesity and morbid obesity of the DiOGenes study
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development
Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development
Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raisingA systematic review and meta-analysis of relevant preclinical studies and clinical trials
Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raisingA systematic review and meta-analysis of relevant preclinical studies and clinical trials
Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia
Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia
Predicting individual responses to pravastatin using a physiologically based kinetic model for plasma cholesterol concentrations
Predicting individual responses to pravastatin using a physiologically based kinetic model for plasma cholesterol concentrations
Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice, a translational model for atherosclerosis
Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice, a translational model for atherosclerosis
The effect of PPE-induced emphysema and chronic LPS-induced pulmonary inflammation on atherosclerosis development in APOE*3-LEIDEN mice
The effect of PPE-induced emphysema and chronic LPS-induced pulmonary inflammation on atherosclerosis development in APOE*3-LEIDEN mice
Comparative transcriptomic and metabolomic analysis of fenofibrate and fish oil treatments in mice
Comparative transcriptomic and metabolomic analysis of fenofibrate and fish oil treatments in mice
A dietary mixture containing fish oil, resveratrol, lycopene, catechins, and vitamins E and C reduces atherosclerosis in transgenic mice
A dietary mixture containing fish oil, resveratrol, lycopene, catechins, and vitamins E and C reduces atherosclerosis in transgenic mice
Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet
Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet
Anti-inflammatory salicylate beneficially modulates pre-existing atherosclerosis through quenching of NF-κB activity and lowering of cholesterol
Anti-inflammatory salicylate beneficially modulates pre-existing atherosclerosis through quenching of NF-κB activity and lowering of cholesterol
The Netherlands twin register biobank: A resource for genetic epidemiological studies
The Netherlands twin register biobank: A resource for genetic epidemiological studies
PXR agonism decreases plasma HDL levels in ApoE*3-Leiden.CETP mice
PXR agonism decreases plasma HDL levels in ApoE*3-Leiden.CETP mice
Searched for: subject%3A%22Cholesterol%255C%2Bblood%255C%2Blevel%22
(1 - 20 of 106)

Pages